Lista de obras - Kazuto Harada - Dominio Público Uruguay

101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy.

artículo científico publicado en 2017

A balancing act: dual immune-checkpoint inhibition for oesophagogastric cancer

artículo científico publicado en 2019

Attenuation of YAP1 can potentially target cancer stem cells to overcome drug resistance

Barrett's Esophagus after Bimodality Therapy in Patients with Esophageal Adenocarcinoma

artículo científico publicado en 2018

Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases

artículo científico publicado en 2020

Cancer stem cells in esophageal cancer and response to therapy

artículo científico publicado en 2018

Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma.

artículo científico publicado en 2016

Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized Trial

artículo científico publicado en 2017

Extracellular vesicles from cancer-associated fibroblasts containing annexin A6 induces FAK-YAP activation by stabilizing β1 integrin, enhancing drug resistance

scientific article published on 30 June 2020

Frequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma

scientific article published on 07 June 2019

Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial

artículo científico publicado en 2017

Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma

artículo científico publicado en 2020

Is phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway therapeutic target for esophageal adenocarcinoma

artículo científico publicado en 2017

Liquid biopsies in gastrointestinal malignancies: when is the big day?

artículo científico publicado en 2017

Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term Survivors

artículo científico publicado en 2016

Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response

artículo científico publicado en 2019

Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients.

artículo científico

Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients.

artículo científico publicado en 2017

Proteomics approach to identify biomarkers for upper gastrointestinal cancer.

artículo científico publicado en 2016

Recent advances in preoperative management of esophageal adenocarcinoma

artículo científico publicado en 2017

Recent advances in the management of gastric adenocarcinoma patients.

artículo científico publicado en 2018

Recent advances in treating oesophageal cancer

artículo científico publicado en 2020

Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma

artículo científico publicado en 2021

Taxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients

scientific article published on 01 February 2020

Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation

scientific article published on 31 January 2019

Translating genomic profiling to gastrointestinal cancer treatment

artículo científico publicado en 2017

Tumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma.

artículo científico publicado en 2017

Utility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma.

artículo científico publicado en 2017

YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition

scientific article published on 27 April 2020

YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer

artículo científico publicado en 2018

Lista de obras de Kazuto Harada

101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy.

A balancing act: dual immune-checkpoint inhibition for oesophagogastric cancer

Attenuation of YAP1 can potentially target cancer stem cells to overcome drug resistance

Barrett's Esophagus after Bimodality Therapy in Patients with Esophageal Adenocarcinoma

Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases

Cancer stem cells in esophageal cancer and response to therapy

Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma.

Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized Trial

Extracellular vesicles from cancer-associated fibroblasts containing annexin A6 induces FAK-YAP activation by stabilizing β1 integrin, enhancing drug resistance

Frequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma

Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial

Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma

Is phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway therapeutic target for esophageal adenocarcinoma

Liquid biopsies in gastrointestinal malignancies: when is the big day?

Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term Survivors

Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response

Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients.

Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients.

Proteomics approach to identify biomarkers for upper gastrointestinal cancer.

Recent advances in preoperative management of esophageal adenocarcinoma

Recent advances in the management of gastric adenocarcinoma patients.

Recent advances in treating oesophageal cancer

Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma

Taxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients

Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation

Translating genomic profiling to gastrointestinal cancer treatment

Tumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma.

Utility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma.

YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition

YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer